Does any BIEL shareholder know the reason for the manufacturing change from CICD in China to Well-Life in Taiwan?? Could the change B due a lower product cost? Could it B due to new tariffs on China? Could it B due to the involvement with Electrome? or requirement of Electrome? Why not use Viant Medical Mfg? Dr. Koneru is on both Bioelectronics Board of Director's & Viant's Board of Director's? A few of my BIEL investor friend's & myself are just trying to connect some dots! Thank's in advance 4 any responses!
Market Data 
Markets 
